Top

Published in:

Open Access 01-12-2023 | Chronic Obstructive Lung Disease | Research

Comparison of the lower limit of normal to the fixed ratio method for the diagnosis of airflow obstruction at high altitudes: a large cross-sectional survey of subjects living between 3000–4700 m above sea level

Authors: Yilin Huang, Zhenzhen Xing, Jean-Paul Janssens, Di Chai, Weiming Liu, Yuxia Wang, Yali Ma, Yaqi Tong, Yanfei Guo

Published in: European Journal of Medical Research | Issue 1/2023

Abstract

Background

There is no general agreement on the preferential use of a fixed ratio (FR) of forced expiratory volume in 1 s (FEV₁)/forced vital capacity (FVC) < 0.7 vs. the lower limit of normal (LLN) of FEV₁/FVC to define airflow obstruction. Determining the impact of these different cut-off levels in people living at high altitudes has not been studied. We assessed the prevalence of airflow obstruction and its clinical characteristics in residents living at high altitude using a fixed ratio and the LLN of FEV₁/FVC according to Global Lung Initiative 2012 (GLI) reference values.

Methods

Using a multistage stratified sampling method, 3702 participants (aged ≥ 15 years) living at an altitude of 3000–4700 m in Tibet were included.

Results

11.4% and 7.7% of participants had airflow obstruction according to GLI-LLN and a fixed FEV₁/FVC cut-off value, respectively. The participants in the FR−/LLN+ group were younger, predominantly female, more frequently exposed to household air pollution, and had a higher proportion of chronic obstructive pulmonary disease assessment test scores ≥ 10 than those in the FR−/LLN− group. They also had a significantly lower FEV₁ and a higher frequency of small airway dysfunction. Compared with the participants of the FR+/LLN+ group, those in the FR−/LLN+ group showed no significant difference in the risk factors for airflow obstruction and respiratory symptoms, but had a lower prevalence of small airway dysfunction.

Conclusions

Defining airflow obstruction according to LLN, instead of using an FR, identified younger individuals with more frequent clinical symptoms of airflow obstruction and small airway dysfunction.

Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–17. https://doi.org/10.1016/S0140-6736(18)30841-9.CrossRefPubMed

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. https://goldcopd.org. Last updated 2021. Last accessed 10 June 2022.

Angelidis I, Simon LM, Fernandez IE, et al. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nat Commun. 2019;10(1):963. https://doi.org/10.1038/s41467-019-08831-9.CrossRefPubMedPubMedCentral

Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43. https://doi.org/10.1183/09031936.00080312.CrossRefPubMedPubMedCentral

Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68. https://doi.org/10.1183/09031936.05.00035205.CrossRefPubMed

Cohen JE, Small C. Hypsographic demography: the distribution of human population by altitude. Proc Natl Acad Sci USA. 1998;95(24):14009–14. https://doi.org/10.1073/pnas.95.24.14009.CrossRefPubMedPubMedCentral

Bai J, Li L, Li Y, Zhang L. Genetic and immune changes in Tibetan high-altitude populations contribute to biological adaptation to hypoxia. Environ Health Prev Med. 2022;27:39. https://doi.org/10.1265/ehpm.22-00040.CrossRefPubMedPubMedCentral

Sangeetha T, Nargis Begum T, Balamuralikrishnan B, et al. Influence of SERPINA1 gene polymorphisms on anemia and chronic obstructive pulmonary disease. J Renin Angiotensin Aldosterone Syst. 2022;2022:2238320. https://doi.org/10.1155/2022/2238320.CrossRefPubMedPubMedCentral

Guo Y, Xing Z, Shan G, et al. Prevalence and risk factors for COPD at high altitude: a large cross-sectional survey of subjects living between 2,100–4,700 m above sea level. Front Med (Lausanne). 2020;7:581763. https://doi.org/10.3389/fmed.2020.581763.CrossRefPubMed

10.

Xing Z, Sun T, Janssens JP, et al. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey. Thorax. 2023;78(3):274–80. https://doi.org/10.1136/thoraxjnl-2021-218345.CrossRefPubMed

11.

Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38. https://doi.org/10.1183/09031936.05.00034805.CrossRefPubMed

12.

Qin R, An J, Xie J, et al. FEF25-75% is a more sensitive measure reflecting airway dysfunction in patients with asthma: a comparison study using FEF25-75% and FEV1. J Allergy Clin Immunol Pract. 2021;9(10):3649-3659.e6. https://doi.org/10.1016/j.jaip.2021.06.027.CrossRefPubMed

13.

Xiao D, Chen Z, Wu S, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081–93. https://doi.org/10.1016/S2213-2600(20)30155-7.CrossRefPubMed

14.

Zheng JP. Textbook of pulmonary function test. Guangdong: Guangdong Science and Technology Press; 2007. (in Chinese).

15.

Office of the Leading Group of the State Council for the Seventh National Population Census. Major figures on 2020 population census of china. Beijing: China Statistics Press; 2021. www.stats.gov.cn/tjsj/pcsj/rkpc/d7c/202111/P020211126523667366751.pdf.

16.

Miele CH, Grigsby MR, Siddharthan T, et al. Environmental exposures and systemic hypertension are risk factors for decline in lung function. Thorax. 2018. https://doi.org/10.1136/thoraxjnl-2017-210477.CrossRefPubMed

17.

Horner A, Soriano JB, Puhan MA, et al. Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study. Respir Res. 2017;18(1):162. https://doi.org/10.1186/s12931-017-0643-5.CrossRefPubMedPubMedCentral

18.

Sakic A, Ekström M, Sharma S, Nilsson PM. Can birth weight predict offspring’s lung function in adult age? Evidence from two Swedish birth cohorts. Respir Res. 2022;23(1):348. https://doi.org/10.1186/s12931-022-02269-2.CrossRefPubMedPubMedCentral

19.

Raju S, Keet CA, Paulin LM, et al. Rural residence and poverty are independent risk factors for chronic obstructive pulmonary disease in the United States. Am J Respir Crit Care Med. 2019;199(8):961–9. https://doi.org/10.1164/rccm.201807-1374OC.CrossRefPubMedPubMedCentral

20.

Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193. https://doi.org/10.1183/13993003.01193-2018.CrossRefPubMedPubMedCentral

21.

Akkermans RP, Biermans M, Robberts B, et al. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers. Eur Respir J. 2014;43(1):54–63. https://doi.org/10.1183/09031936.00158212.CrossRefPubMed

22.

Gershon AS, Hwee J, Chapman KR, et al. Factors associated with undiagnosed and overdiagnosed COPD. Eur Respir J. 2016;48(2):561–4. https://doi.org/10.1183/13993003.00458-2016.CrossRefPubMed

23.

Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Young and middle-aged adults with airflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival: a population-based prospective cohort study. Eur Respir J. 2018;51(3):1702681. https://doi.org/10.1183/13993003.02681-2017.CrossRefPubMed

24.

Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prevalence, characteristics, and prognosis of early chronic obstructive pulmonary disease. The Copenhagen general population study. Am J Respir Crit Care Med. 2020;201(6):671–80. https://doi.org/10.1164/rccm.201908-1644OC.CrossRefPubMedPubMedCentral

25.

Liu S, Zhou Y, Liu S, et al. Clinical impact of the lower limit of normal of FEV1/FVC on detecting chronic obstructive pulmonary disease: a follow-up study based on cross-sectional data. Respir Med. 2018;139:27–33. https://doi.org/10.1016/j.rmed.2018.04.011.CrossRefPubMed

26.

Turkeshi E, Vaes B, Andreeva E, et al. Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults. Eur Respir J. 2015;46(1):123–32. https://doi.org/10.1183/09031936.00217214.CrossRefPubMed

27.

Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest. 2012;141(1):73–80. https://doi.org/10.1378/chest.11-0797.CrossRefPubMed

28.

Çolak Y, Nordestgaard BG, Vestbo J, Lange P, Afzal S. Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort. Thorax. 2020;75(11):944–54. https://doi.org/10.1136/thoraxjnl-2020-214559.CrossRefPubMed

29.

McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–75. https://doi.org/10.1056/NEJMoa1106955.CrossRefPubMedPubMedCentral

30.

Air pollution. https://www.who.int/health-topics/air-pollution. Accessed 3 Mar 2023.

31.

Qiu AY, Leng S, McCormack M, Peden DB, Sood A. Lung effects of household air pollution. J Allergy Clin Immunol Pract. 2022;10(11):2807–19. https://doi.org/10.1016/j.jaip.2022.08.031.CrossRefPubMed

32.

Gut-Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD: do we need more evidence? Eur Respir Rev. 2019;28(151):180055. https://doi.org/10.1183/16000617.0055-2018.CrossRefPubMedPubMedCentral

33.

Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014;2(10):823–60. https://doi.org/10.1016/S2213-2600(14)70168-7.CrossRefPubMedPubMedCentral

34.

Meteran H, Miller MR, Thomsen SF, Christensen K, Sigsgaard T, Backer V. The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms. ERJ Open Res. 2017;3(4):00110–2017. https://doi.org/10.1183/23120541.00110-2017.CrossRefPubMedPubMedCentral

35.

Ma L, Jiang M, Wei J, et al. Fixed ratio versus lower limit of normal: health status and risk factors for COPD overdiagnosis. Respir Care. 2020;65(5):603–9. https://doi.org/10.4187/respcare.07069.CrossRefPubMed

Title: Comparison of the lower limit of normal to the fixed ratio method for the diagnosis of airflow obstruction at high altitudes: a large cross-sectional survey of subjects living between 3000–4700 m above sea level
Authors: Yilin Huang
Zhenzhen Xing
Jean-Paul Janssens
Di Chai
Weiming Liu
Yuxia Wang
Yali Ma
Yaqi Tong
Yanfei Guo
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Chronic Obstructive Lung Disease
Spirometry
Published in: European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/s40001-023-01151-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparison of the lower limit of normal to the fixed ratio method for the diagnosis of airflow obstruction at high altitudes: a large cross-sectional survey of subjects living between 3000–4700 m above sea level

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Intention to use maternal waiting home and its predictors among pregnant women in Ethiopia: systematic review and meta-analysis

Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia–reperfusion injury

Abnormal expression of fission and fusion genes and the morphology of mitochondria in eutopic and ectopic endometrium

Causal relationship between sarcopenia and osteoarthritis: a bi-directional two-sample mendelian randomized study

Role of tranexamic acid-soaked gelatin sponge in minimizing rectus sheath hematoma after cesarean section in women treated with warfarin, a simple tool for high-risk cases, a randomized controlled trial

Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas